Sareum Holdings PLC made an announcement noting that Sierra Oncology presented as the 2021 Cantor Virtual Global Healthcare Conference. We have published research on this which is attached and a snapshot of the research is below.
Sareum Holdings PLC, the specialist drug development company today made an announcement noting that Sierra Oncology (NASDAQ:SRRA), the licence holder for SRA737 (a novel Chk1 inhibitor), presented at 21.00 BST on 28 September at the 2021 Cantor Virtual Global Healthcar ....
29 Sep 2021
Hybridan Research: Sareum Holdings plc: 29/09/21: Potential for SRA737 value crystallisation as Sierra eyes up combination studies in H1 2022
Sign up to access
Get access to our full offering from over 100 providers
Get access to our full offering from over 100 providers
Hybridan Research: Sareum Holdings plc: 29/09/21: Potential for SRA737 value crystallisation as Sierra eyes up combination studies in H1 2022
Sareum Holdings plc (SAR:LON) | 15.5 0.1 3.3% | Mkt Cap: 21.4m
- Published:
29 Sep 2021 - Author:
-
Pages:
7 -
Sareum Holdings PLC made an announcement noting that Sierra Oncology presented as the 2021 Cantor Virtual Global Healthcare Conference. We have published research on this which is attached and a snapshot of the research is below.
Sareum Holdings PLC, the specialist drug development company today made an announcement noting that Sierra Oncology (NASDAQ:SRRA), the licence holder for SRA737 (a novel Chk1 inhibitor), presented at 21.00 BST on 28 September at the 2021 Cantor Virtual Global Healthcar ....